cholesterol biosynthesis inhibitor blocks staphylococcus aureus virulence
staphylococcus aureus produces hospital community acquired infections methicillin resistant s aureus posing serious public health threat golden carotenoid pigment s aureus staphyloxanthin promotes resistance reactive oxygen species host neutrophil based killing early enzymatic steps staphyloxanthin production resemble cholesterol biosynthesis determined crystal structures s aureus dehydrosqualene synthase crtm angstrom resolution finding structural similarity human squalene synthase sqs screened nine sqs inhibitors determined structures three bound crtm one previously tested cholesterol lowering activity humans blocked staphyloxanthin biosynthesis vitro median inhibitory concentration similar nm resulting colorless bacteria increased susceptibility killing human blood innate immune clearance mouse infection model finding represents proof principle virulence factor based therapy s aureus
